Testing effectiveness (Phase 2)Study completedNCT02178709What this trial is testingA Phase II Study of Neoadjuvant FOLFIRINOXWho this might be right forResectable Pancreatic Ductal Adenocarcinoma Indiana University 48
Large-scale testing (Phase 3)Study completedNCT03766295What this trial is testingMasitinib Plus Gemcitabine in Pancreatic CancerWho this might be right forLocally Advanced or Metastatic Pancreatic Cancer AB Science 377
Large-scale testing (Phase 3)UnknownNCT02117895What this trial is testingLeft Celiac Plexus Resection for Pancreatic Cancer at the Body and TailWho this might be right forPancreatic Cancer Fudan University 180
Early research (Phase 1)Study completedNCT02237157What this trial is testingA Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic CancerWho this might be right forPancreatic Cancer RenovoRx 20
Not applicableLooking for participantsNCT07552467What this trial is testingSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsWho this might be right forPancreatic CancerBreast CancerLung Cancer+5 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 26
Large-scale testing (Phase 3)Study completedNCT02184195What this trial is testingOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyWho this might be right forGermline BRCA1/2 Mutations andMetastatic Adenocarcinoma of the Pancreas AstraZeneca 154
Testing effectiveness (Phase 2)Study completedNCT02005419What this trial is testingMetformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionWho this might be right forStage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more Xian-Jun Yu 300
Testing effectiveness (Phase 2)Study completedNCT01587534What this trial is testingPancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)Who this might be right forPancreatic Cancer National Cancer Center, Korea 67
Testing effectiveness (Phase 2)Looking for participantsNCT07629609What this trial is testingBEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in CancerWho this might be right forPancreatic Cancer, AdultGastroesophageal Cancer (GC) Barbara Malene Fischer 90
Testing effectiveness (Phase 2)WithdrawnNCT05251038What this trial is testingStudy of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas CancerWho this might be right forPancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more Devalingam Mahalingam
Early research (Phase 1)Study completedNCT01487785What this trial is testingDose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsWho this might be right forPancreatic Cancer Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT03723915What this trial is testingPembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8 Northwestern University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476What this trial is testingSurufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Neoplasms Sun Yat-sen University 32
Early research (Phase 1)Not Yet RecruitingNCT07707674What this trial is testingPhase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Evopoint Biosciences Inc. 24
Large-scale testing (Phase 3)Looking for participantsNCT07219238What this trial is testingStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)Who this might be right forColorectal CancerGastric CancersOvarian Cancers+1 more GE Healthcare 175
Not applicableApproved For MarketingNCT00786058What this trial is testingA Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003Who this might be right forPancreatic Cancer CONKO-Studiengruppe
Not applicableLooking for participantsNCT06287749What this trial is testingFrench Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)Who this might be right forPancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more University Hospital, Montpellier 37
Not applicableNot Yet RecruitingNCT07839676What this trial is testingA Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)Who this might be right forBorderline and Locally Advanced Pancreatic Cancer Fernando Pessoa Canarias University 60
Not applicableStudy completedNCT01807325What this trial is testingRNA Sequencing of Solid and Cystic Lesions of the PancreasWho this might be right forPancreas CystPancreas Mass Oregon Health and Science University 72
Testing effectiveness (Phase 2)Study completedNCT02403271What this trial is testingA Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsWho this might be right forNon-Small Cell Lung CancerBreast CancerPancreatic Cancer Pharmacyclics LLC. 124